Named Bioactive Compounds · Compound
Menthol
Strong Evidencemonoterpenoid
Hermetica Superfood Encyclopedia
Menthol is a monoterpenoid compound that activates TRPM8 cold receptors to produce cooling and analgesic effects. It provides topical pain relief and respiratory support through direct receptor binding mechanisms.
Menthol is a naturally occurring cyclic monoterpene alcohol (C₁₀H₂₀O) primarily extracted from Mentha arvensis (cornmint) and Mentha piperita (peppermint) plants via steam distillation, followed by crystallization at low temperatures (−40°C). L-menthol, the naturally occurring form, comprises approximately 65% of crude menthol extract after crystallization, with extraction yields varying from 2.4-5.36% depending on the method used.
The provided research dossier notably lacks specific clinical trial data, PMIDs, or detailed human studies, focusing instead on extraction methodologies and chemical composition. The document explicitly states this gap: 'The search results provided do not contain specific PubMed PMIDs or detailed human clinical trial data.' To obtain evidence-based clinical information, direct consultation of PubMed using search terms like 'menthol clinical trial' and 'peppermint oil RCT' would be required.
Essential oil yields 2.4-5.36% menthol from plant material via steam distillation. Topical preparations typically contain 1-16% menthol in creams/ointments. Peppermint oil capsules commonly contain 0.2-0.4 mL per enteric-coated capsule. Crystallized menthol achieves 52.3% yield from essential oil at -40°C. Consult a healthcare provider before starting any new supplement.
Menthol (C₁₀H₂₀O, molecular weight 156.27 g/mol) is a monocyclic monoterpenoid alcohol, not a nutrient, and therefore lacks a conventional nutritional profile (no caloric value, no macronutrients, no vitamins or minerals). Key bioactive characteristics: • Primary active isomer: (−)-menthol (L-menthol), which constitutes >99% of naturally derived menthol from Mentha × piperita (peppermint) and related species. • Natural peppermint oil contains approximately 30–50% free menthol and 1–10% menthyl acetate (an ester prodrug that hydrolyzes to menthol in vivo). • Menthol acts as a potent TRPM8 (transient receptor potential melastatin 8) channel agonist with an EC₅₀ of approximately 4–80 µM depending on assay conditions; also modulates TRPA1 channels and voltage-gated sodium channels at higher concentrations. • Additional bioactive terpenoid companions in natural peppermint-derived menthol include menthone (14–32%), 1,8-cineole (eucalyptol, 3–7%), limonene (1–5%), and pulegone (<1% in high-quality oil). • Oral bioavailability is high (estimated >50–70%), with rapid first-pass hepatic glucuronidation; primary metabolite is menthol glucuronide, which is renally excreted with a plasma half-life of approximately 1.5–3 hours. • Topical bioavailability through intact skin is moderate; penetration-enhancing properties allow approximately 2–5% systemic absorption from dermal application depending on vehicle and concentration (typically formulated at 1–16% w/w for topical analgesic products). • No protein, fiber, fat, or carbohydrate content. No vitamins or minerals. • Typical therapeutic doses: 0.1–0.2 mL of peppermint oil orally (enteric-coated, delivering ~30–90 mg menthol per capsule) for gastrointestinal use; 1–5% topical solutions or creams for analgesic/counterirritant use; inhaled via steam at concentrations of ~0.01–0.1% for respiratory applications. • Menthol is classified as GRAS (Generally Recognized as Safe) by the FDA for food use at concentrations up to approximately 0.1–0.4% in food products.
Menthol activates TRPM8 (transient receptor potential melastatin 8) cold-sensitive ion channels in sensory neurons, triggering calcium influx and cooling sensations. This activation inhibits voltage-gated sodium channels, reducing pain signal transmission and producing local analgesic effects. In respiratory tissues, menthol stimulates cold receptors in nasal passages, creating sensations of improved airflow.
Clinical evidence for menthol primarily comes from topical analgesic formulations containing 1-16% menthol concentrations. Small-scale studies have demonstrated pain reduction in conditions like osteoarthritis and muscle soreness, though large randomized controlled trials are limited. Inhalation studies show subjective improvements in nasal congestion symptoms, but objective airflow measurements show minimal changes. Most evidence relies on traditional use and mechanistic studies rather than comprehensive clinical trials.
Menthol is generally recognized as safe for topical and inhalation use at recommended concentrations. High concentrations (>20%) may cause skin irritation, contact dermatitis, or paradoxical burning sensations. Oral consumption of large amounts can cause respiratory depression, particularly in infants and young children. Menthol may interact with medications metabolized by cytochrome P450 enzymes and should be avoided in individuals with G6PD deficiency.
